LEUVEN, Belgium and OSAKA, Japan, March 23, 2018 /PRNewswire/ —
– First allogeneic stem cell therapy to receive central marketing authorization approval in Europe – Alofisel offers a new treatment option for patients who do not respond to current available therapies and may be subje…
